Stroke
Conditions
Keywords
Stroke
Brief summary
The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.
Detailed description
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.
Interventions
None listed
Sponsors
Center for Stroke Research Berlin
German Federal Ministry of Education and Research
Charite University, Berlin, Germany
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* all patients eligible
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness. | September 2010 |
Secondary
| Measure | Time frame |
|---|---|
| Compliance/adherence with discharge medication Activities of daily living | September 2010 |
| Re-events | September 2010 |
| Degree of Disability | September 2010 |
| Mortality | September 2010 |
Countries
Germany
Outcome results
None listed